Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05063305
Other study ID # 5210331
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 27, 2021
Est. completion date January 27, 2022

Study information

Verified date February 2022
Source Loma Linda University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this graduate student research study is to evaluate the efficacy of a multi-strain probiotic and investigate if sex differences influence the role of probiotics on stress and immunity biomarkers.


Description:

Visit #1 - Participants will read and sign informed consent forms, HIPPA form, and SAHP Covid-19 screening form. - Participants will perform a baseline oral saliva swab to test for the stress biomarker cortisol and immune markers, including Interleukin-1β (IL-1β) and Tumor Necrosis Factor (TNF). - Swabs will be individually packaged. After opening the package, participants will place the swab under their tongue for 1-2 minutes. - After swabbing is complete, the swab will be placed into the collection tube and capped immediately. - Completed swabs will be placed and held in a sub negative 70° Fahrenheit freezer. - Participants will complete a Quality-of-Life Questionnaire (10-15 minutes). - As this study is double blinded, participants will be separated by gender (male and female) and will select a 90-day supply of placebo or probiotic sample at random. For each gender group there will be 50 samples to select from, comprised of a mix of 25 placebo and 25 probiotic bottles. - Participants will be instructed to take 1 capsule per day for the following 90 days. If a participant misses a day, they should resume taking 1 capsule per day the next day. The capsule should not be crushed or chewed. The capsule may be taken with or without food per participant preference. The participant should consistently take the probiotic at a similar time each day (example: always take it in the morning or evening) Visit #2 - Participants will complete the same Quality-of-Life Questionnaire from visit #1 - Participants will perform a post-study oral saliva swab in the same manner as visit #1


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date January 27, 2022
Est. primary completion date January 27, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Males and Females - 18-90 years of age - Participants should be of good health Exclusion Criteria: - Women who are self-reported as pregnant and/or breastfeeding - Those who suffer from any systemic illness, such as diabetes mellitus, HIV, cancer, or chronic kidney disease. - Persons who are diagnosed with clinical depression or anxiety, or other mental health diagnoses such as schizophrenia or Alzheimer's. - Persons who have taken any probiotic for 5 or more days in the 3 months prior to the trial - Persons having received antibiotics or non-steroid anti-inflammatory therapy in the last 3-month period prior to the study - Persons who work night shift - Persons who consume probiotic rich foods daily, such as yogurt, kimchi, kombucha, kefir, sauerkraut, tempeh, miso, and buttermilk - Anyone who is allergic to any ingredient in the probiotic or placebo

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Probiotic
The probiotic to be used in the study is in capsule form and consists of 12 bacterial strains and 10-billion colony forming unit (CFU). The product consists of the following bacterial strains and species: Bifidobacterium infantis ATCC SD 6720, Bifidobacterium bifidum ATCC SD 6576, Bifidobacterium breve ATCC SD 5206, Bifidobacterium lactis ATCC SD 5220, Bifidobacterium longum ATCC SD 5588, Lactobacillus acidophilus DSM 32754, Lactobacillus casei ATCC SD5213, Lactobacillus paracasei ATCC SD 5275, Lactobacillus plantarum ATCC SD 5209, Lactobacillus reuteri ATCC SD 6689, Lactobacillus rhamnosus ATCC 53103, Lactobacillus salivarius ATCC SD 5208) in combination with the prebiotic, xylooligosacharide (XOS).
Placebo
A placebo, that will be indistinguishable in appearance to the probiotic, will be provided to half of all study participants for the length of the trial. It will contain the following ingredients: Microcrystalline cellulose, magnesium stearate, a vegetarian capsule, and silicon dioxide. The probiotic will be manufactured by MeriCal.

Locations

Country Name City State
United States Loma Linda University Loma Linda California

Sponsors (2)

Lead Sponsor Collaborator
Loma Linda University MeriCal LLC

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Saliva Sample Cortisol Baseline and post-study oral saliva samples will be tested for the stress biomarker cortisol uL. Change in cortisol uL between baseline and 90 days
Secondary Saliva Sample IL-1 Baseline and post-study oral saliva samples will be tested for Interleukin-1ß (IL-1ß) uL. Change in Interleukin-1ß (IL-1ß) uL between baseline and 90 days
Secondary Saliva Sample Tumor Necrosis Factor Baseline and post-study oral saliva samples will be tested for Tumor Necrosis Factor (TNF) uL. Change in Tumor Necrosis Factor (TNF) uL between baseline and 90 days
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT06238557 - Prospective Evaluation of Psychological Consequences and Impact on Long-term Quality of Life
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT05472935 - Asynchronous Mindfulness Based Stress Reduction to Reduce Burnout in Licensed Clinical Social Workers N/A
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04281953 - Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors
Active, not recruiting NCT04746664 - Effects of Nutrition Counselling on Old Age People's Nutritional Status and Quality of Life in Bahir Dar City, North West Ethiopia N/A
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Recruiting NCT04142827 - The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX) N/A
Active, not recruiting NCT05903638 - A Pilot RCT: the Impact of a Virtual MBSR Course on Women With Primary Infertility N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT03813420 - Sleep Quality of Physiotherapy Students Quality of Life and Physical Activity Level N/A
Recruiting NCT05550545 - Infant RSV Infections and Health-related Quality of Life of Families
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Recruiting NCT05233020 - Robotic Versus Hybrid Assisted Ventral Hernia Repair N/A
Terminated NCT03304184 - The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life Phase 3
Recruiting NCT05380856 - Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction N/A
Completed NCT05934578 - Lymphatic Function in Patients With Fontan Circulation: Effect of Physical Training N/A
Completed NCT04059809 - Photobiomodulation for Breast Cancer Radiodermatitis Phase 2/Phase 3